Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
|Articles|March 15, 2003
Pfizer, Pharmacia probe focuses on competition
New York-The European Commission is wrapping up its investigation into a proposed merger of pharmaceutical giants Pfizer Inc. and Pharmacia Corp.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
2
Duravyu misses wet AMD end point again as EyePoint pivots to DME
3
The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD
4
A vascular link: erectile dysfunction may signal glaucoma risk in men
5